Pathology of diacetyl and 2,3-pentanedione airway lesions in a rat model of obliterative bronchiolitis

Toxicology

Volumn 388, Issue , 2017, Pages 40-47

  Flake, Gordon P ^a   Morgan, Daniel L ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

2,3 Pentanedione; Diacetyl; Histopathology; Obliterative bronchiolitis; Pathogenesis

Indexed keywords

2,3 BUTANEDIONE; 2,3 PENTANEDIONE; ACETYLACETONE; UNCLASSIFIED DRUG; 2,3-PENTANEDIONE; ALKANONE; FLAVORING AGENT;

AIRWAY OBSTRUCTION; ARTICLE; BASEMENT MEMBRANE; BRONCHIOLE EPITHELIUM; BRONCHIOLITIS OBLITERANS; BRONCHITIS; CELL PROLIFERATION; CIRCUMFERENTIAL AIRWAY FIBROSIS; EXPOSURE; FIBROBLAST; FIBROSIS; INTRALUMINAL POLYPOID FIBROSIS; NONHUMAN; OBLITERATIVE AIRWAY FIBROSIS; PATHOGENESIS; POLYP; PRIORITY JOURNAL; RAT; RESPIRATORY EPITHELIUM; TISSUE INJURY; TISSUE REPAIR; ADVERSE EFFECTS; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; HUMAN; MALE; OCCUPATIONAL EXPOSURE; PATHOLOGY; RESPIRATORY MUCOSA; SPECIES DIFFERENCE; WISTAR RAT;

ANIMALS; BASEMENT MEMBRANE; BRONCHIOLITIS OBLITERANS; DIACETYL; DISEASE MODELS, ANIMAL; FLAVORING AGENTS; HUMANS; INHALATION EXPOSURE; MALE; OCCUPATIONAL EXPOSURE; PENTANONES; RATS; RATS, WISTAR; RESPIRATORY MUCOSA; SPECIES SPECIFICITY;

EID: 85006710904     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2016.10.013     Document Type: Article

References (18)

1. Afessa, B., Peters, S.G., Major complications following hematopoietic stem cell transplantation. Semin. Respir. Crit. Care Med. 27 (2006), 297–309.
2. Babu, A.N., Nichols, M.R., Critical pathways leading to obliterative bronchiolitis in lung allografts. Curr. Opin. Organ Transplant. 11 (2006), 483–489.
3. Babu, A.N., Murakawaa, T., Thurman, J.M., Miller, E.J., Henson, P.M., Zamora, M.R., Voelkel, N.F., Nicolls, M.R., Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis. J. Clin. Invest. 117 (2007), 3774–3785.
4. Fernandez, F.G., Jaramillo, A., Chen, C., Liu, D.Z., Tung, T., Patterson, G.A., Mohanakumar, T., Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am. J. Transplant. 4 (2004), 319–325.
5. Gunn, M.L.D., Godwin, J.D., Kanne, J.P., Flowers, M.E., Chien, J.W., High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. J. Thorac. Imaging 23 (2008), 244–250.
6. King, T.E., Miscellaneous causes of bronchiolitis: inhalational, infectious, drug-induced and idiopathic. Semin. Respir. Crit. Care Med. 24 (2003), 567–576.
7. Kreiss, K., Gomaa, A., Kullman, G., Fedan, K., Simoes, E.J., Enright, P.L., Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N. Engl. J. Med. 347 (2002), 330–338.
8. Morgan, D.L., Jokinen, M.P., Price, H.C., Gwinn, W.M., Palmer, S.M., Flake, G.P., Bronchial and bronchiolar fibrosis in rats exposed to 2 3-pentanedione vapors: implications for bronchiolitis obliterans in humans. Toxcol. Pathol. 40 (2012), 448–465.
9. Morgan, D.L., Jokinen, M.P., Johnson, C.L., Price, H.C., Gwinn, W.M., Bousquet, R.W., Flake, G.P., Chemical reactivity and respiratory toxicity of the alpha-diketone flavoring agents: 2,3-butanedione 2,3-pentanedione, and 2, 3-hexanedione. Toxcol. Pathol. 44 (2016), 763–783.
10. Morris, J.B., Hubbs, A.F., Inhalation dosimetry of diacetyl and butyric acid, two components of butter flavoring vapors. Toxicol. Sci. 108 (2009), 173–183.
11. Myer, K.C., Diagnosis and management of bronchiolitis obliterans syndrome following lung or hematopoietic cell transplantation. Expert Rev. Resp. Med. 10 (2016), 599–602.
12. O'Koren, E.G., Hogan, B.L.M., Gunn, M.D., Loss of basal cells precedes bronchiolitis obliterans-like pathological changes in a murine model of chlorine gas inhalation. Am. J. Respir. Cell Mol. Biol. 49 (2013), 788–797.
13. Ropponen, J.O., Syrjala, S.O., Krebs, R., Nykanen, A., Tikkanen, J.M., Lemstrom, K.B., Innate and adaptive immune responses in obliterative airway disease in rat tracheal allografts. J. Heart Lung Transplant. 30 (2011), 707–716.
14. Segel, G.B., Halterman, M.W., Lichtman, M.A., The paradox of the neutrophil's role in tissue injury. J. Leukoc. Biol. 89 (2011), 359–372.
15. Sharples, L.D., McNeil, K., Stewart, S., Wallwork, J., Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J. Heart Lung Transplant. 21 (2002), 271–281.
16. Siddiqui, M.T., Garrity, E.R., Martinez, R., Hussain, A.N., Bronchiolar basement membrane changes and bronchiolitis obliterans in lung allografts study. Mod. Pathol. 9 (1996), 320–328.
17. Snell, G.I., Westall, G.P., The contribution of airway ischemia and vascular remodelling to the pathophysiology of bronchiolitis obliterans syndrome and chronic lung allograft dysfunction. Curr. Opin. Organ Transplant. 15 (2010), 558–562.
18. Weigt, S.S., DerHovanessian, A., Wallace, W.D., Lynch, J.P., Belperio, J.A., Bronchiolitis obliterans syndrome: the achilles’ heel of lung transplantation. Semin. Respir. Crit. Care Med. 34 (2013), 336–351.